HBO2 THERAPEUTICS   Report issue

For profit
Founded: Souderton PA United States (2014)
Status: Left NME R&D (2021)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

HbO2 Therapeutics LLC

Active Ingredients

Drugs in Other Trials (1)

hemoglobin glutamer 250 (2 trials)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 1